The authors present an overview of adverse effects associated with intramuscular injections and factors contributing to these effects. Guidelines for both general and critical care patients are proposed after evaluating available research and case history literature. Recommendations include re-evaluating the appropriateness of the intramuscular route for administration of drugs to critical care patients. Avoidance of this route for most critically ill patients is suggested
This content is only available as a PDF.
©1994 American Association of Critical-Care Nurses
1994
You do not currently have access to this content.